# Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

> **NCT01115543** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 32 (actual)

## Conditions studied

- Secondary Hyperparathyroidism
- End Stage Renal Disease

## Interventions

- **DRUG:** alfacalcidol and calcitriol

## Key facts

- **NCT ID:** NCT01115543
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115543, "Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01115543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*